November 25, 2013

VIDEO: OLYSIO™ (simeprevir) receives US FDA approval


Provided by Janssen

Novenber 22, 2013

OLYSIO™(simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C

OLYSIO™ is the first once-daily protease inhibitor approved for the treatment of chronic hepatitis C in a combination antiviral regimen for adults with compensated liver disease.

See Press Release here 

No comments:

Post a Comment